Vialwirebiotech, curated
September 29, 2026, 11:20 PM
September 29, 2026
- 1:56 PM · STAT News1:56 PMSTAT+: PhRMA taps Eric Cantor as new CEO — STAT News
- 1:54 PM · STAT News
- 1:00 PM · Pharmaceutical Executive1:00 PM<![CDATA[New U.S. Guidance Lays Out Exemptions for 100% Tariffs: Report ]]> — Pharmaceutical Executive
- 12:24 PM · Drug Discovery World12:24 PMScarlet secures $14m DARPA deal for smart red blood cells — Drug Discovery World
- 12:00 PM · BioWorld12:00 PMBeyond Rasonque: deeper, broader and more durable — BioWorld
- 12:00 PM · BioWorld12:00 PMOtsuka, Ionis notch phase III win in FUS-ALS — BioWorld
- 12:00 PM · BioWorld12:00 PMTolerance Bio expands thymus platform via $560M Tanabe deal — BioWorld
- 12:00 PM · BioWorld12:00 PMMerck licenses SPR-2015 from China’s Scibrunch in $2B+ deal — BioWorld
- 12:00 PM · BioWorld12:00 PMEarendil’s AI platform lands $1.5B Genentech collaboration — BioWorld
- 12:00 PM · BioWorld12:00 PMSweden’s Egetis wins FDA approval of Emcitate for MCT8 deficiency — BioWorld
- 12:00 PM · BioWorld12:00 PMItalian newco Aptadir raises €40M seed round for RNA inhibitors — BioWorld
- 11:52 AM · BioPharma Dive11:52 AMNovo to pay Hengrui up to $2.6B for a once-weekly obesity pill — BioPharma Dive
- 10:08 AM · Pharmaceutical Executive10:08 AM<![CDATA[Pharming CEO Fabrice Chouraqui Steps Down Amid Strategic Disagreement with Board]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMNovo licenses rights to Hengrui’s HRS-1596 — BioWorld
- 9:00 AM · BioPharma Dive9:00 AMai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’ — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMCurrus Biologics’ CUR-001 gains IND clearance for solid tumors — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMIregene’s Nouvsight-001 cleared for clinic in US and China — BioWorld
- 8:49 AM · BioPharma Dive8:49 AMAstraZeneca invests $2B in Summit, gaining ‘seat at the table’ for PD-1/VEGF drug push — BioPharma Dive
- 7:05 AM · STAT News
- 6:50 AM · Drug Discovery World6:50 AMMagnitude Biosciences secures £1.3m investment — Drug Discovery World
- 6:32 AM · Pharmaceutical Technology6:32 AMMSD bets $2.13bn on SciBrunch’s KRAS (ON) inhibitor — Pharmaceutical Technology
- 5:00 AM · SCMP — Tech5:00 AMAstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows — SCMP — Tech
September 28, 2026
- 4:45 PM · STAT News
- 12:11 PM · BioPharma Dive12:11 PMKodiak skyrockets on positive study data for 2 eye drugs — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMAbbvie’s Juvmo FDA approval brings new Parkinson’s option — BioWorld
- 12:00 PM · BioWorld12:00 PMSofinnova closes fourth fund for early stage med tech at €82M — BioWorld
- 12:00 PM · BioWorld12:00 PMMirum wins Atebrioz nod in FOP and reports positive HDV trial — BioWorld
- 11:52 AM · BioPharma Dive11:52 AMAn ‘off-the-shelf’ CAR-T therapy from Adicet shows promise against lupus — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMJapan AMED grant supports Sola’s SOL-257 for ALS — BioWorld
- 9:00 AM · BioWorld9:00 AMFDA approves IND for Nutshell’s NRF2 degrader NTS-231 — BioWorld
- 8:52 AM · BioPharma Dive8:52 AMMerck, Daiichi end plans to seek speedy approval of lung cancer ADC — BioPharma Dive
- 8:50 AM · PharmaVoice8:50 AMWhat Bavarian Nordic’s next CEO is up against — PharmaVoice
- 4:00 AM · Drug Discovery World4:00 AMSkylark Bio expands gene therapy pipeline into CNS — Drug Discovery World
- 12:00 AM · SCMP — Tech12:00 AMChina lights up ‘super microscope’ hopes with world-leading electron gun beam — SCMP — Tech